Corcept Therapeutics Cash on Hand 2012-2025 | CORT

Corcept Therapeutics cash on hand from 2012 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Corcept Therapeutics Annual Cash on Hand
(Millions of US $)
2024 $383
2023 $368
2022 $432
2021 $224
2020 $441
2019 $276
2018 $207
2017 $89
2016 $52
2015 $40
2014 $24
2013 $55
2012 $93
2011 $40
Corcept Therapeutics Quarterly Cash on Hand
(Millions of US $)
2025-09-30 $422
2025-06-30 $342
2025-03-31 $323
2024-12-31 $383
2024-09-30 $380
2024-06-30 $473
2024-03-31 $411
2023-12-31 $368
2023-09-30 $355
2023-06-30 $363
2023-03-31 $465
2022-12-31 $432
2022-09-30 $396
2022-06-30 $370
2022-03-31 $346
2021-12-31 $224
2021-09-30 $361
2021-06-30 $370
2021-03-31 $373
2020-12-31 $441
2020-09-30 $429
2020-06-30 $405
2020-03-31 $307
2019-12-31 $276
2019-09-30 $232
2019-06-30 $202
2019-03-31 $187
2018-12-31 $207
2018-09-30 $195
2018-06-30 $160
2018-03-31 $125
2017-12-31 $89
2017-09-30 $75
2017-06-30 $66
2017-03-31 $53
2016-12-31 $52
2016-09-30 $48
2016-06-30 $42
2016-03-31 $41
2015-12-31 $40
2015-09-30 $36
2015-06-30 $37
2015-03-31 $38
2014-12-31 $24
2014-09-30 $27
2014-06-30 $34
2014-03-31 $44
2013-12-31 $55
2013-09-30 $63
2013-06-30 $72
2013-03-31 $81
2012-12-31 $93
2012-09-30 $102
2012-06-30 $35
2012-03-31 $43
2011-12-31 $40
2011-09-30 $46
2011-06-30 $52
2011-03-31 $59
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.035B $0.675B
Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.845B 31.38
Takeda Pharmaceutical (TAK) Japan $56.639B 11.12
Zoetis (ZTS) United States $55.849B 19.99
BeOne Medicines - (ONC) Switzerland $38.053B 201.74
Sandoz Group AG (SDZNY) Switzerland $34.527B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.382B 17.12
United Therapeutics (UTHR) United States $20.621B 18.15
Merck (MKKGY) Germany $18.598B 11.47
Shionogi (SGIOY) Japan $18.477B 14.29
Neurocrine Biosciences (NBIX) United States $13.752B 33.00
Ionis Pharmaceuticals (IONS) United States $13.522B 0.00
IPSEN (IPSEY) France $13.306B 0.00
Orion OYJ (ORINY) Finland $11.502B 32.86
Summit Therapeutics (SMMT) United States $10.680B 0.00
Madrigal Pharmaceuticals (MDGL) United States $10.525B 0.00
Eisai (ESAIY) $8.400B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.149B 17.10
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.947B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.643B 22.05
Crinetics Pharmaceuticals (CRNX) United States $4.576B 0.00
Indivior Pharmaceuticals (INDV) United States $4.307B 17.58
Stevanato Group S.p.A (STVN) Italy $4.285B 23.98
NewAmsterdam Pharma (NAMS) Netherlands $3.635B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.164B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.939B 9.38
Hypermarcas (HYPMY) Brazil $2.793B 19.17
Dyne Therapeutics (DYN) United States $2.364B 0.00
Soleno Therapeutics (SLNO) United States $2.126B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.109B 0.00
Guardian Pharmacy Services (GRDN) United States $2.081B 40.08
Ocular Therapeutix (OCUL) United States $1.898B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.880B 22.28
Harrow (HROW) United States $1.706B 104.68
Ardelyx (ARDX) United States $1.701B 0.00
Enliven Therapeutics (ELVN) United States $1.602B 0.00
Definium Therapeutics (DFTX) United States $1.601B 0.00
Oruka Therapeutics (ORKA) United States $1.521B 0.00
Collegium Pharmaceutical (COLL) United States $1.483B 7.34
Amylyx Pharmaceuticals (AMLX) United States $1.427B 0.00
Relay Therapeutics (RLAY) United States $1.413B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.315B 78.00
Evotec AG (EVO) Germany $1.251B 0.00
Xeris Biopharma Holdings (XERS) United States $1.147B 0.00
Savara (SVRA) United States $1.050B 0.00
Theravance Biopharma (TBPH) United States $0.992B 41.66
Aktis Oncology (AKTS) United States $0.991B 0.00
Cronos Group (CRON) Canada $0.977B 0.00
ARS Pharmaceuticals (SPRY) United States $0.956B 0.00
Xencor (XNCR) United States $0.773B 0.00
Esperion Therapeutics (ESPR) United States $0.760B 0.00
KalVista Pharmaceuticals (KALV) United States $0.728B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.724B 17.11
Nektar Therapeutics (NKTR) United States $0.714B 0.00
Bioventus (BVS) United States $0.679B 13.91
Rigel Pharmaceuticals (RIGL) United States $0.603B 5.38
Altimmune (ALT) United States $0.555B 0.00
ProKidney (PROK) United States $0.520B 0.00
Lexeo Therapeutics (LXEO) United States $0.503B 0.00
Lyell Immunopharma (LYEL) United States $0.481B 0.00
4D Molecular Therapeutics (FDMT) United States $0.479B 0.00
Organogenesis (ORGO) United States $0.471B 0.00
Zevra Therapeutics (ZVRA) United States $0.471B 0.00
Aquestive Therapeutics (AQST) United States $0.468B 0.00
Siga Technologies (SIGA) United States $0.466B 6.38
Nature's Sunshine Products (NATR) United States $0.459B 27.33
Elite Pharmaceuticals (ELTP) United States $0.405B 0.00
USANA Health Sciences (USNA) United States $0.380B 10.62
Aclaris Therapeutics (ACRS) United States $0.367B 0.00
Akebia Therapeutics (AKBA) United States $0.366B 0.00
Protara Therapeutics (TARA) United States $0.336B 0.00
Aldeyra Therapeutics (ALDX) United States $0.306B 0.00
Cybin (HELP) Canada $0.292B 0.00
Journey Medical (DERM) United States $0.278B 0.00
Enlivex Therapeutics (ENLV) Israel $0.275B 0.00
Relmada Therapeutics (RLMD) United States $0.264B 0.00
Larimar Therapeutics (LRMR) United States $0.254B 0.00
Avalo Therapeutics (AVTX) United States $0.243B 0.00
OmniAb (OABI) United States $0.238B 0.00
Profound Medical (PROF) Canada $0.229B 0.00
Heron Therapeutics (HRTX) United States $0.222B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Silence Therapeutics (SLN) United Kingdom $0.214B 0.00
Achieve Life Sciences (ACHV) Canada $0.210B 0.00
Context Therapeutics (CNTX) United States $0.208B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
Galectin Therapeutics (GALT) United States $0.182B 0.00
Surrozen (SRZN) United States $0.182B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.182B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
AleAnna (ANNA) United States $0.173B 0.00
VAXART, INC (VXRT) United States $0.150B 0.00
Century Therapeutics (IPSC) United States $0.146B 0.00
Unicycive Therapeutics (UNCY) United States $0.133B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.130B 0.00
Prelude Therapeutics (PRLD) United States $0.127B 0.00
Avita Medical (RCEL) United States $0.120B 0.00
Inhibikase Therapeutics (IKT) United States $0.119B 0.00
Karyopharm Therapeutics (KPTI) United States $0.112B 0.00
Korro Bio (KRRO) United States $0.109B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.106B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
Pyxis Oncology (PYXS) United States $0.096B 0.00
Cassava Sciences (SAVA) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.091B 38.41
Incannex Healthcare (IXHL) Australia $0.087B 0.00
Assertio Holdings (ASRT) United States $0.075B 0.00
PolyPid (PYPD) Israel $0.069B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Rafael Holdings (RFL) United States $0.061B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Liminatus Pharma (LIMN) United States $0.055B 0.00
Dominari Holdings (DOMH) United States $0.055B 0.00
Fractyl Health (GUTS) United States $0.055B 0.00
PMV Pharmaceuticals (PMVP) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.054B 44.88
Nutriband (NTRB) United States $0.053B 0.00
BioNxt Solutions (BNXTF) Canada $0.052B 0.00
Acrivon Therapeutics (ACRV) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Lipocine (LPCN) United States $0.043B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Telomir Pharmaceuticals (TELO) United States $0.039B 0.00
Talphera (TLPH) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Lite Strategy (LITS) United States $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.032B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Wellgistics Health (WGRX) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.028B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Scienture Holdings (SCNX) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Inotiv (NOTV) United States $0.013B 0.00
Vyome Holdings (HIND) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
CASI Pharmaceuticals (CASI) China $0.012B 0.00
Tempest Therapeutics (TPST) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
BioVie (BIVI) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Ernexa Therapeutics (ERNA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Lyra Therapeutics (LYRA) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
China SXT Pharmaceuticals (SXTC) China $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00